Health Care: Drugs

aTyr Pharma Inc (LIFE: NASDAQ)

$4.11 n/a | n/a%
02/12/16 - 04:00 PM ET
Company Income Statement
Dec 2014
Sales 0.00
Cost of Sales 0.00
Gross Operating Profit 0.00
Selling, General, and Administrative Expenses 6.78M
Research & Development 16.78M
Operating Income before D & A (EBITDA) -23.55M
Depreciation & Amortization 1.30M
Interest Income 0.00
Other Income - Net 36.00K
Special Income / Charges 0.00
Total Income Before Interest Expenses (EBIT) -24.82M
Interest Expense 832.00K
Pre-Tax Income -25.65M
Income Taxes 0.00
Minority Interest 0.00
Net Income From Continuing Operations -24.35M
Net Income From Discontinued Operations 0.00
Net Income From Total Operations -24.35M
Extraordinary Income/Losses 0.00
Income From Cum. Effect of Acct. Change 0.00
Income From Tax Loss Carryforward 0.00
Other Gains / Losses 0.00
Total Net Income -24.35M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
Preferred Dividends
Net Income Available To Common -24.77M
Basic EPS from Continuing Ops. -2.46
Basic EPS from Discontinued Ops. 0.00
Basic EPS from Total Operations -2.46
Basic EPS from Extraordinary Inc. 0.00
Basic EPS from Cum Effect of Accounting Change 0.00
Basic EPS from Tax Loss Carryf'd. 0.00
Basic EPS from Other Gains (Losses) 0.04
Basic EPS, Total -2.42
Basic Normalized Net Income/Share -2.46
EPS fr Continuing Ops. -2.46
EPS fr Discontinued Ops 0.00
EPS fr Total Ops. -2.46
EPS fr Extraord. Inc. 0.00
EPS fr Cum Effect of Accounting Change 0.00
EPS fr Tax Loss Carfd. 0.00
EPS fr Other Gains (L) 0.04
EPS, Total -2.42
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
Dividends Paid per Share 0.00

Portfolios with LIFE

Latest LIFE Headlines from TheStreet

More Financial News for LIFE

Press Releases for LIFE

See All Press Releases

Partner Headlines for LIFE

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter